Resurrection Healthcare is a clinical research site located in Chicago, Illinois, United States 60631.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Resurrection Healthcare has participated in 6 clinical trials.
Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Sponsors: ECOG-ACRIN Cancer Research Group, Canadian Cancer Trials Group, National Cancer Institute (NCI).
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Resurrection Healthcare has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Resurrection Healthcare has 6 clinical trials on record. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.
Yes — Resurrection Healthcare holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.